Health3 hours ago
Ianalumab Enhances Treatment Outcomes in Immune Thrombocytopenia Patients
Patients with immune thrombocytopenia (ITP) who received the investigational drug ianalumab alongside standard therapy experienced significantly longer periods without treatment failure compared to those given a...